Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Aggrenox 25mg/200mg Capsule MR: Preventing Blood Clots and Strokes
Introduction:
Aggrenox 25mg/200mg Capsule MR is a combination of two medications primarily aimed at preventing clot formation in the blood vessels. It also helps prevent recurrent stroke in patients with a history of prior stroke or transient ischemic attack (mini-stroke).
Key Information:
Type of Medication: Combination antiplatelet therapy
Active Ingredients: Aspirin and Dipyridamole
Administration: Should be taken with food regularly at the same time each day
Uses of Aggrenox 25mg/200mg Capsule:
Prevention of Blood Clots: Aggrenox 25mg/200mg Capsule MR is utilized to prevent the formation of blood clots, particularly in individuals at risk of stroke or other clot-related conditions.
Benefits of Aggrenox 25mg/200mg Capsule:
In Prevention of Blood Clots:
Antiplatelet Action: Aggrenox 25mg/200mg Capsule MR inhibits platelet aggregation, preventing the formation of blood clots within the blood vessels and arteries.
Reduced Risk of Cardiovascular Events: By maintaining blood flow and preventing clot formation, this medication helps reduce the risk of heart attack, stroke, deep vein thrombosis, and pulmonary embolism.
Prevention of Stroke Recurrence: In patients with a history of prior stroke or transient ischemic attack (TIA), Aggrenox reduces the likelihood of recurrent stroke, thereby improving long-term outcomes and reducing disability.
Combination Therapy: The combination of Aspirin and Dipyridamole in Aggrenox provides dual antiplatelet effects, enhancing its efficacy in preventing clot formation and stroke recurrence.
Mechanism of Action of Aggrenox 25mg/200mg Capsule:
Dual Antiplatelet Therapy: Aggrenox 25mg/200mg Capsule MR combines the actions of two antiplatelet medications, Aspirin and Dipyridamole. Aspirin inhibits platelet aggregation by blocking the formation of thromboxane A2, a potent platelet aggregator. Dipyridamole acts synergistically with Aspirin to further inhibit platelet function, thereby reducing the risk of stroke and other thrombotic events.